CLINICAL_TRIALS
trial_result
· 2023-01-30
Clinical Trial Update: SP16 Inflammatory Response Inhibition Trial [Phase 1, Phase 2]
Summary
Clinical trial update for SP16 inflammatory response inhibition shows completed Phase 1 and Phase 2 studies with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Serpin Pharma, LLC | Conditions: Myocardial Infarction, Inflammation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-01-30